MEETINGS - US Medical Device Manufacturers Association holds Second Annual Coverage and Reimbursement Conference (US) December 1999:
This article was originally published in Clinica
The US Medical Device Manufacturers Association is holding its Second Annual Coverage and Reimbursement Conference in Philadelphia on December 6. Topics for discussion include: recent changes to the Medicare coverage process, including the new Medicare Coverage Advisory Committee; how specific Medicare coverage criteria will be developed; obtaining proper medical procedure codes; working with and gaining support of medical societies; and general strategies and best practices for navigating the coverage and reimbursement mazes. For more information contact Shannon Dunn at +1 202 496 7150 or register online at www.medicaldevices.org
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.